A recent National Academies of Sciences, Engineering, and Medicine report details several adverse impacts from poor diversity in clinical trials. These include lack of access to effective medical interventions, compounding of health disparities in underrepresented and excluded populations, and hindering innovation. Read the Full Article.
Home / Community / Lack of diversity in clinical trials costs billions of dollars. Incentives can spur innovation
Recent Posts
- Rutgers NJHealth Study Data Access Opportunity – Application Due July 6th!
- Rutgers researchers: How Meta turned teen attention into a public health crisis.
- Kids under 5 are grabbing their parents’ vapes and getting sick at record levels, researchers say.
- These N.J. medical schools are among some of the best in the country. See how they rank.
- Estrogen Patch Shortages Are Ongoing—Here’s Where to Find Them and What to Ask Your Doctor.
Categories
- Community (2,497)
- Covid (1,001)
- CTO Events (6)
- News (3,170)
- Pilots (21)